Potentiation of immune checkpoint blockade cancer immunotherapy with oncolytic virus.

Oncolytic viruses and their application to cancer immunotherapy

Viruses for tumor therapy

Genetically engineered Newcastle disease virus expressing interleukin 2 is a potential drug candidate for cancer immunotherapy

Localized oncolytic virotherapy overcomes systemic tumor resistance to immune checkpoint blockade immunotherapy

Two is better than one: Complementing oncolytic virotherapy with gemcitabine to potentiate antitumor immune responses

Different responses of human pancreatic adenocarcinoma cell lines to oncolytic Newcastle disease virus infection

Oncolytic viruses as therapeutic cancer vaccines